Overview

Vagus Nerve Stimulation Market is poised to register a CAGR of 11.4% during the forecast period 2022 to 2028.

Vagus nerve is a crucial part of the autonomic nervous systems that controls involuntary body functions like heart rate. It passes from the abdomen to the lower part of the brain via chest and neck. Vagus nerve stimulation therapy is developed to prevent seizures by consistently sending mild electrical pulses through the vagus nerve to the brain. The VNS device is referred as the ‘brain pacemaker’ and it is placed on the chest wall under the skin. The vagus nerve is connected to the device using a wire. Vagus nerve stimulators are used for curing treatment resistant depression and intractable epilepsy.
The rising incidences of neurological disorders like epilepsy, obtaining efficient clinical outcomes using this technique are some crucial factors contributing to the vagus nerve stimulation market growth. Conversely, a lack of skilled healthcare professionals and step costs related with these devices shall restrain the market growth. On the other hand, rising research and development activities for expanding the range of applications of using neurostimulators shall provide substantial growth opportunities to the market.

Market Segmentation:

By Product
•   Implantable VNS Devices
•   External VNS Devices
By Application
•   Depression
•   Epilepsy
•   Migraine
By Biomaterial
•   Ceramics
•   Metallic
•   Polymerics
By End User
•   Hospitals
•   Ambulatory Surgical Centers
•   Others
By Region
•   North America
•   Europe
•   Asia-Pacific
•   Latin America
•   Middle East and Africa

The market is classified into product, application, biomaterial, end user and region. The product segment is fragmented into implantable VNS devices and external VNS devices. The external VNS devices are predicted to hold the largest vagus nerve stimulation market share as the process of fitting this device is minimally invasive, which is highly preferred by patients and is also a cheaper alternative than an implantable VNS device. The application segment is categorised into depression, epilepsy and migraine. The depression segment is predicted to lead the market as VNS devices are primarily used for treating treatment resistant depression. The biomaterial segment is divided into ceramic, metallic and polymerics. The end user segment is categorised into hospitals, ambulatory surgical centres and others. The hospital segment is anticipated to dominate the market owing to advancements in the hospital infrastructure, rise in the number of multispecialty hospitals and rising patient population across the world.

Regional Analysis:

The North America region is predicted to dominate the market owing to a strong presence of key market players in the region. Furthermore, unprecedented advancements in the healthcare infrastructure in the region shall boost its market growth. Additionally, there has been a rising awareness amongst patients regarding neurological disorders and alternatives to treat them.

Competitive Landscape:

Some of the crucial market players are Medtronic Plc., ElectroCore LLC, LivaNova Plc., Boston Scientific Corporation, Aleva Neurotherapeutics SA, BioControl Medical, Bioness Inc., EnteroMedics Inc., Nevro Corporation, NeuroPace Inc.

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key market trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the global vagus nerve stimulation market by product, by application, by biomaterial, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•   We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•   The customization Mobility Care offered are free of charge with purchase of any license of the report
•   You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com